Literature DB >> 22970051

Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells.

Jie-Tao Ma1, Cheng-Bo Han, Jian-Zhu Zhao, Wei Jing, Yang Zhou, LE-Tian Huang, Hua-Wei Zou.   

Abstract

The aim of this study was to evaluate the effects of recombinant human adenovirus p53 (rAd-p53; Gendicine) transfection and radiation at various time points following transfection. Cytotoxic effects and p53 protein expression levels were analyzed. rAd-p53 containing the human wild-type p53 gene was introduced into the human lung adenocarcinoma cell line A549, and cells were irradiated with a single dose of 6 MeV 4 Gy β rays. According to the time interval between rAd-p53 transfection and radiotherapy (RT), A549-transfected rAd-p53 cells were divided into 5 groups: radiation administered immediately after transfection (0 h-RT) group, after 3 h group (3 h-RT), after 6 h group (6 h-RT), after 24 h group (24 h-RT) and after 48 h group (48 h-RT). Cells with rAd-p53 transfection alone (Ad-p53) and with empty adenovirus (Ad) were included as the two control groups. Following 72 h of transfection, cell viability and growth were analyzed using MTT assays and flow cytometry, and p53 protein expression was analyzed using western blot analysis. From 0 h-RT to 48 h-RT, cell viability gradually decreased, while percentage of apoptotic cells and p53 protein expression gradually increased. The cell viability suppression rates in the 6 h-RT, 24 h-RT and 48 h-RT groups were 56.7±5.4, 60.8±6.0 and 68.9±6.6, respectively, which were significantly greater compared to that of the Ad-p53 (40.8±4.7), 0 h-RT (45.0±3.5) and 3 h-RT groups (47.0±4.3). No statistically significant differences were observed in the cell viability suppression rates among the 6 h-RT, 24 h-RT and 48 h-RT groups (P>0.05). Similar changes were observed in the percentage of apoptotic cells. The p53 protein expression level in the 6 h-RT group (0.856±0.092) was higher compared to that in the 3 h-RT group (0.643±0.089) (t=2.882; P=0.045), but not significantly different from that of the 24 h-RT group (1.193±0.202). The cell viability suppression rate and percentage of apoptotic cells was positively correlated with p53 protein expression in the A549 cells (P<0.05). Radiation may inhibit or damage p53 protein expression at the early stage of rAd-p53 transfection. To sensitize tumor cells to irradiation and achieve maximal cytotoxic effects, it is recommended to conduct RT at least 6 h following transfection with rAd-p53.

Entities:  

Year:  2012        PMID: 22970051      PMCID: PMC3438999          DOI: 10.3892/ol.2012.747

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

Review 1.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Authors:  A Hirao; Y Y Kong; S Matsuoka; A Wakeham; J Ruland; H Yoshida; D Liu; S J Elledge; T W Mak
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

Review 3.  Adenovirus p53 gene therapy.

Authors:  Jack A Roth
Journal:  Expert Opin Biol Ther       Date:  2006-01       Impact factor: 4.388

Review 4.  Regulation of p53 in response to DNA damage.

Authors:  N D Lakin; S P Jackson
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

Review 5.  Prospective therapeutic applications of p53 inhibitors.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Biochem Biophys Res Commun       Date:  2005-06-10       Impact factor: 3.575

6.  TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.

Authors:  Daniela Kandioler; Ronald Zwrtek; Carmen Ludwig; Elisabeth Janschek; Meinhard Ploner; Friedrich Hofbauer; Irene Kührer; Sonja Kappel; Friedrich Wrba; Manfred Horvath; Josef Karner; Karl Renner; Michael Bergmann; Judith Karner-Hanusch; Richard Pötter; Raimund Jakesz; Bela Teleky; Friedrich Herbst
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

7.  Regulation of p53 function and stability by phosphorylation.

Authors:  M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 8.  Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.

Authors:  Cheng-long Huang; Hiroyasu Yokomise; Akira Miyatake
Journal:  Future Oncol       Date:  2007-02       Impact factor: 3.404

9.  Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.

Authors:  Jian-ji Pan; Shan-wen Zhang; Chuan-beng Chen; Shao-wen Xiao; Yan Sun; Chang-qin Liu; Xing Su; Dong-ming Li; Gang Xu; Bo Xu; You-yong Lu
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

10.  Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status.

Authors:  G Ma; K Kawamura; Q Li; N Suzuki; M Liang; M Namba; H Shimada; M Tagawa
Journal:  Cancer Gene Ther       Date:  2009-04-10       Impact factor: 5.987

View more
  6 in total

1.  Recombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation.

Authors:  Jinluan Li; Jianji Pan; Xianggao Zhu; Ying Su; Lingling Bao; Sufang Qiu; Changyan Zou; Yong Cai; Junxin Wu; Ivan W K Tham
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

2.  Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells.

Authors:  Hong Xie; Jia Hu; Huan Pan; Yaxin Lou; Ping Lv; Yingyu Chen
Journal:  BMB Rep       Date:  2014-02       Impact factor: 4.778

3.  Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.

Authors:  Rong Biaoxue; Pan Hui; Gao Wenlong; Yang Shuanying
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

Review 4.  Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.

Authors:  Cheng Yuan; Xin-Hua Xu; Zhuo Chen
Journal:  Springerplus       Date:  2016-10-27

5.  Effect of the p53α gene on the chemosensitivity of the H1299 human lung adenocarcinoma cell line.

Authors:  Kaishan Liu; Weisong Gao; Jun Lin
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

6.  Copy Number Analysis Reveal Genetic Risks of Penile Cancer.

Authors:  Yongbo Yu; Chengwen Gao; Yuanbin Chen; Meilan Wang; Jianfeng Zhang; Xiaocheng Ma; Shuaihong Liu; Hang Yuan; Zhiqiang Li; Haitao Niu
Journal:  Front Oncol       Date:  2020-12-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.